Chaffetz and Cummings Investigate Dramatic Price Increases for EpiPens
Oversight Committee Requests Documents and Communications Related to Mylan Price Hike
Reps. Jason Chaffetz (R-UT) and Elijah E. Cummings (D-MD), the Chairman and Ranking Member of the House Committee on Oversight and Government Reform, sent a letter to Heather Bresch, the CEO of Mylan, requesting documents and communications regarding the increasing price of EpiPens.
“Mylan has a virtual monopoly over the epinephrine auto-injector market,” Chaffetz and Cummings wrote. “While families and schools are struggling to keep up with your company’s unreasonable price increases, Mylan has profited richly from its pricing strategy.”
Chaffetz and Cummings are requesting documents to better understand the increasing cost of EpiPens, including documents relating to the company’s revenues from sales of EpiPens since 2007, manufacturing costs, and the amount of money the company receives from federal government health care programs.
The House Oversight Committee has asked for a private meeting with executives from the pharmaceutical company Mylan…thehill.com
Drugmaker Mylan said Monday that it will offer a generic version of the life-saving allergy treatment EpiPen for half…www.usatoday.com
Democratic and Republican lawmakers on the Congressional House Oversight Committee have launched an investigation into…abcnews.go.com
The House Oversight and Government Reform Committee has launched an investigation into drugmaker Mylan, which is facing…www.washingtonpost.com
The House Committee on Oversight and Government Reform is investigating Mylan, the pharmaceutical company under fire…morningconsult.com
Mylan's attempts to quiet a public anger over its $600 price tag for EpiPen weren't enough to escape a congressional…www.washingtonexaminer.com
WASHINGTON - Doubling down on efforts to stem widespread condemnation for the skyrocketing price of EpiPens, drugmaker…www.dallasnews.com